Abstract:Objective:To explore the genetic mutation, clinical characteristics, diagnosis and treatment of patients with hereditary coagulation factor FⅪ deficiency.Methods:On August 10 and October 30, 2020, two patients with hereditary FⅪ deficiency who were admitted at Department of Hematology, West China Hospital of Sichuan University were selected as research subjects. Patients 1 and 2 were numbered according to visiting time. Diagnosis was made according to coagulation function test and results of gene sequencing F11 gene.Clinical observation or symptomatic treatment were performed according to clinical bleeding symptom and severity. Novel mutations were confirmed by retrieving Human Gene Mutation database (HGMD), Single Nucleotide Polymorphism Database (dbSNP) and PubMed database. Pathogenicity of the novel missense mutation was predicted by computational software of Mutation Taster, Polyphen-2, and PROVEAN. Follow-up of patients was conducted until February 28, 2021. Clinical manifestations and process of diagnosis and treatment of two patients were analyzed retrospectively. China National Knowledge Infrastructure database, Wanfang Data Knowledge Service Platform, PubMed database were searched for the same and similar case reports as F11 genetic mutation in this study.Retrieval time was from database inception to February 28, 2021. Types of genetic mutations and clinical manifestations related to patients in this study were summarized.This study meeted the requirements of the World Medical Association Declaration of Helsinki revised in 2013. Informed consent of patients was obtained from pateints. Results:① Results of medical history: patient 1, a 24 years old man, was admitted due to " hematoma after soft tissue trauma in left thigh and preoperative examination revealed coagulation dysfunction" and did not complain of significant discomfort.Patient 2, a 32 years old woman, was admitted due to " pre-pregnancy physical examination found prolonged activated partial thromboplastin time (APTT)" and complained of occasional ecchymosis.② Results of related laboratory examination: APTT, prothrombin time (PT) and FⅪ activity (FⅪ∶C) of patient 1 were 97.9 s, 11.9 s and 0.6%, while patient 2 were 95.4 s, 12.5 s, and 1.2%, respectively. ③ Results of DNA sequencing: patient 1 had a compound heterozygous missense mutation of F11 gene at c. 149G>T(p.Cys50Phe) and c. 1204C>T (p.Gln402Ter), while patient 2 had a homozygous deletion of F11 gene at c. 1058delA (p.Asn353ThrfsTer18). ④ F11 gene missense mutation at c. 149G>T(p.Cys50Phe) and deletion c. 1058delA(p.Asn353ThrfsTer18) were two novel mutations and both were pathogenic.⑤Results of treatment and follow-up: two patients received clinical observation. At end of follow-up, general condition of the patients was good. ⑥ Results of literatures review: among 10 patients reported in 6 relevant literatures, there were 1, 3, 6 patients caused by heterozygous nonsense mutation of c. 1204C>T(p.Gln402Ter), nonsense mutation of c. 1202C>T(p.Trp401Ter) adjacent to c. 1204C>T (p.Gln402Ter) and missense mutations near the position of c. 149G>T(p.Cys50Phe), respectively. Conclusions:Two novel mutations of hereditary FⅪ deficiency namely a missense mutation at c. 149G>T(p.Cys50Phe) and a deletion at c. 1058delA(p.Asn353ThrfsTer18) of F11 gene were reported in this study. Both of the two mutations related to decrease of FⅪ∶C.

Gene Analysis of Five Inherited Factor V Deficiency Cases

Identification of Gene Mutations in Two Coagulation Factor V Deficiency Patients

[Clinical and Genetic Analyses of Hereditary Factor Ⅴ Deficiency Cases].

Genetic analysis of patients with hereditary coagulation factor Ⅺ deficiency and literatures review

Two Novel Factor V Gene Mutations Associated with Congenital Coagulation Factor V Deficiency, Study of One Pedigree

Severe hereditary coagulation factor V deficiency caused by two novel heterozygous mutations]

Ser234Leu Missense Mutation in the A1 Domain of Factor V Causing Moderate Factor V Deficiency in a Chinese Family

[Analysis of Phenotype and Genotype in Four Chinese Pedigrees with Inherited Coagulation Factor V Deficiency.].

Type I Coagulation Factor V Deficiency Caused by Compound Heterozygous Mutation of F5 Gene

Molecular characterisation of Tyr530Ser and IVS16–1G>T mutations causing severe factor V deficiency:

Laboratory Diagnosis of a Pedigree with Inherited Coagulation Factor V Deficiency

Identification of a novel mutation of human blood coagulation FV gene associated with congenital FV deficiency]

Genetic Mutation Analysis of a Pedigree with Hereditary Coagulation Factor Ⅻ Deficiency Caused by Two Compound Heterozygous Mutations : Arg36Gln and Ala324Pro

Phenotypic And Genotypic Characterization Of Four Factor Vii Deficiency Patients From Central China

Analysis of Clinical Phenotype and Genotype of Two Hereditary Coagulation Factor Ⅻ Deficiency

[Two Novel Mutations in One Pedigree with Hereditary Factor VII Deficiency].

Structural and Functional Characterization of Novel F7 Mutations Identified in Chinese Factor VII-deficient Patients.

A novel molecular mechanism of congenital FV deficiency: mutation in the intron acceptor splice site of human blood coagulation FV gene]

Analysis of the factor Ⅻ gene mutations in two Chinese pedigrees with congenital clotting factor Ⅻ deficiency

Factor V haemostatic diathesis impairing thrombin activation, membrane binding and circulating antigen level due to a novel compound heterozygous mutation, Leu1821Ser and Gly2192Cys

[Genotype and Phenotype Analysis of Congenital Coagulator Factor VII Deficiency in Four Chinese Pedigrees].